Global Rotateq Market Report 2025

Rotateq Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Type (Rotarix, Rotavac), By Clinical Indication (Primary Indication, Infants (6 To 32 Weeks), Mild To Moderate Gastroenteritis, Prevention Of Severe Rotavirus Gastroenteritis (RGE)), By Distribution Channel (Hospitals, Clinics, Pharmacies)

Rotateq Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Rotateq Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

What Is Covered Under Rotateq Market?

RotaTeq is an oral vaccine that protects infants and young children from severe rotavirus infections, which cause diarrhea and vomiting. It contains weakened rotavirus strains to stimulate immunity, administered in a series of doses starting at 2 months of age to prevent dehydration and hospitalization.

The main types of rotateq are rotarix and rotavac. Rotarix refers to a vaccine developed to prevent gastroenteritis caused by rotavirus in infants, helping to protect against severe diarrhea and dehydration. The various clinical indications include primary indication, infants (6 to 32 weeks), mild to moderate gastroenteritis, and prevention of severe rotavirus gastroenteritis (RGE) and are distributed through several channels such as hospitals, clinics, and pharmacies.

What Is The Rotateq Market Size 2025 And Growth Rate?

The rotateq market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased spread of vector-borne diseases, demand for rapid diagnostics, increased healthcare expenditure and government initiatives, increased awareness, and increased vaccine production.

What Is The Rotateq Market Growth Forecast?

The rotateq market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing prevalence and incidence of infectious diseases, increasing demand for rapid diagnostic solutions, increasing occurrences of infectious diseases, rising health awareness, and increasing prevalence of chronic diseases. Major trends in the forecast period include technological innovations, product approvals, product launches, collaborations and partnerships, and geographic expansions.

Rotateq Market Size and growth rate 2025 to 2029: Graph

How Is The Rotateq Market Segmented?

The rotateq market covered in this report is segmented –

1) By Type: Rotarix; Rotavac

2) By Clinical Indication: Primary Indication; Infants (6 To 32 Weeks); Mild To Moderate Gastroenteritis; Prevention Of Severe Rotavirus Gastroenteritis (RGE)

3) By Distribution Channel: Hospitals; Clinics; Pharmacies

What Is Driving The Rotateq Market? Impact Of Rising Rotavirus Prevalence On The Growth Of The Market

The increasing prevalence of rotavirus is expected to propel the growth of the rotateq market going forward. Rotavirus is a highly contagious virus that causes severe diarrhea, vomiting, and dehydration, primarily affecting infants and young children. The increasing prevalence of rotavirus is largely due to low vaccination rates and poor sanitation, which facilitate its spread, especially in developing regions. Rotateq is an oral vaccine used to protect infants against rotavirus by stimulating the immune system to produce antibodies that prevent severe diarrhea and dehydration. For instance, in August 2024, according to the GOV.UK, a UK-based government agency, the cumulative number of rotavirus laboratory reports in England up to week 21 of 2024 was 7% higher than the 5-season average. Additionally, rotavirus activity in weeks 18 to 21 of 2024 was 28% above the 5-season average and 37% higher compared to the previous 4-week period. Therefore, increasing prevalence of rotavirus is driving the growth of the rotateq market.

What Is Driving The Rotateq Market? Impact Of Rising Healthcare Expenditure On The Growth Of The Market

The increasing healthcare expenditure is expected to propel the growth of the rotateq market going forward. Healthcare expenditure encompasses the total money spent on medical services, treatments, and health-related activities by individuals, governments, and organizations, covering costs for hospitals, medications, insurance, and public health programs. Healthcare expenditure is rising due to factors such as aging populations, advancements in medical technology, the increasing prevalence of chronic diseases, rising healthcare prices, expanded access to care, and the aftermath of the COVID-19 pandemic. Healthcare expenditure is beneficial for rotateq as it increases investments in preventive healthcare, supporting the widespread adoption of vaccines like rotateq to combat rotavirus infections. For instance, in May 2023, according to the Office for National Statistics, a UK-based government department, UK healthcare expenditure totaled around $354.88 billion (£283 billion) in 2022, showing a nominal increase of 0.7% compared to 2021. Therefore, the increasing healthcare expenditure is driving the growth of the rotateq market.

What Is Driving The Rotateq Market? Rising Adoption Of Personalized Medicine Is Expected To Propel The Growth Of The Market

The rising adoption of personalized medicine is expected to propel the growth of the rotateq market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to the individual characteristics, needs, and preferences of each patient. The rising adoption of personalized medicine is due to genomics, increasing availability of precision diagnostic tools, growing demand for targeted therapies, and the need for more effective, patient-specific treatments to improve outcomes and reduce adverse effects. RotaTeq, as a vaccine specifically designed to prevent rotavirus infections, contributes to personalized medicine by addressing individual patient needs based on risk factors such as age, geographic prevalence, and health conditions, thereby aligning preventive healthcare strategies with tailored medical approaches to improve patient outcomes. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, 12 new personalized medicines were approved, accounting for roughly 34% of all newly authorized therapies, marking a significant rise compared to the previous year. Therefore, the rising adoption of personalized medicine is driving the growth of the rotateq market.

Who Are The Major Players In The Global Rotateq Market?

Major companies operating in the rotateq market are Merck & Co. Inc.

Regional Analysis For The Global Rotateq Market

North America was the largest region in the rotateq market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotateq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rotateq market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rotateq Market?

The rotateq market consists of sales of products including the oral vaccine dropper, oral vaccine suspension bottles, oral dosing syringe, and measuring cups or oral dosing cups. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rotateq Industry?

The rotateq market research report is one of a series of new reports from The Business Research Company that provides rotateq market statistics, including rotateq industry global market size, regional shares, competitors with a rotateq market share, detailed rotateq market segments, market trends and opportunities, and any further data you may need to thrive in the rotateq industry. This rotateq market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rotateq Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The rotateq market covered in this report is segmented –
1) By Type: Rotarix; Rotavac
2) By Clinical Indication: Primary Indication; Infants (6 To 32 Weeks); Mild To Moderate Gastroenteritis; Prevention Of Severe Rotavirus Gastroenteritis (RGE)
3) By Distribution Channel: Hospitals; Clinics; Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rotateq Market Characteristics

    3. Rotateq Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Rotateq Market Trends And Strategies

    5. Rotateq Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Rotateq Growth Analysis And Strategic Analysis Framework

    6.1. Global Rotateq PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Rotateq Market Growth Rate Analysis

    6.4. Global Rotateq Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Rotateq Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Rotateq Total Addressable Market (TAM)

    7. Global Rotateq Pricing Analysis & Forecasts

    8. Rotateq Market Segmentation

    8.1. Global Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Rotarix

    Rotavac

    8.2. Global Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Primary Indication

    Infants (6 To 32 Weeks)

    Mild To Moderate Gastroenteritis

    Prevention Of Severe Rotavirus Gastroenteritis (RGE)

    8.3. Global Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Clinics

    Pharmacies

    9. Global Rotateq Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Rotateq Market Regional And Country Analysis

    10.1. Global Rotateq Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Rotateq Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Rotateq Market

    11.1. Asia-Pacific Rotateq Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Rotateq Market

    12.1. China Rotateq Market Overview

    12.2. China Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Rotateq Market

    13.1. India Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Rotateq Market

    14.1. Japan Rotateq Market Overview

    14.2. Japan Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Rotateq Market

    15.1. Australia Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Rotateq Market

    16.1. South Korea Rotateq Market Overview

    16.2. South Korea Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Rotateq Market

    17.1. Western Europe Rotateq Market Overview

    17.2. Western Europe Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Rotateq Market

    18.1. UK Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Rotateq Market

    19.1. Germany Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Rotateq Market

    20.1. France Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Rotateq Market

    21.1. Eastern Europe Rotateq Market Overview

    21.2. Eastern Europe Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Rotateq Market

    22.1. North America Rotateq Market Overview

    22.2. North America Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Rotateq Market

    23.1. USA Rotateq Market Overview

    23.2. USA Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Rotateq Market

    24.1. Canada Rotateq Market Overview

    24.2. Canada Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Rotateq Market

    25.1. South America Rotateq Market Overview

    25.2. South America Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Rotateq Market

    26.1. Middle East Rotateq Market Overview

    26.2. Middle East Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Rotateq Market

    27.1. Africa Rotateq Market Overview

    27.2. Africa Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Rotateq Market Competitive Landscape And Company Profiles

    28.1. Rotateq Market Competitive Landscape

    28.2. Rotateq Market Company Profiles

    28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Rotateq Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Rotateq Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Rotateq Market

    32. Recent Developments In The Rotateq Market

    33. Rotateq Market High Potential Countries, Segments and Strategies

    33.1 Rotateq Market In 2029 - Countries Offering Most New Opportunities

    33.2 Rotateq Market In 2029 - Segments Offering Most New Opportunities

    33.3 Rotateq Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Rotateq Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Rotateq Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Rotateq Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Rotateq Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Rotateq Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Rotateq Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Rotateq Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Merck & Co. Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Rotateq market?

RotaTeq is an oral vaccine that protects infants and young children from severe rotavirus infections, which cause diarrhea and vomiting. It contains weakened rotavirus strains to stimulate immunity, administered in a series of doses starting at 2 months of age to prevent dehydration and hospitalization. For further insights on the Rotateq market, request a sample here

How will the Rotateq market drivers and restraints affect the market dynamics? What forces will shape the Rotateq industry going forward?

The Rotateq market major growth driver - Impact Of Rising Rotavirus Prevalence On The Growth Of The Market. For further insights on the Rotateq market, request a sample here

What is the forecast market size or the forecast market value of the Rotateq market?

The Rotateq market size has grown strongly in recent years. The rotateq market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased spread of vector-borne diseases, demand for rapid diagnostics, increased healthcare expenditure and government initiatives, increased awareness, and increased vaccine production. The rotateq market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing prevalence and incidence of infectious diseases, increasing demand for rapid diagnostic solutions, increasing occurrences of infectious diseases, rising health awareness, and increasing prevalence of chronic diseases. Major trends in the forecast period include technological innovations, product approvals, product launches, collaborations and partnerships, and geographic expansions. For further insights on the Rotateq market, request a sample here

How is the Rotateq market segmented?

The rotateq market covered in this report is segmented –
1) By Type: Rotarix; Rotavac
2) By Clinical Indication: Primary Indication; Infants (6 To 32 Weeks); Mild To Moderate Gastroenteritis; Prevention Of Severe Rotavirus Gastroenteritis (RGE)
3) By Distribution Channel: Hospitals; Clinics; Pharmacies For further insights on the Rotateq market,
request a sample here

Which region has the largest share of the Rotateq market? What are the other regions covered in the report?

North America was the largest region in the rotateq market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotateq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Rotateq market, request a sample here.

Who are the major players in the Rotateq market?

Major companies operating in the rotateq market are Merck & Co. Inc. . For further insights on the Rotateq market, request a sample here.

What are the key trends in the Rotateq market?

Major trends in the Rotateq market include . For further insights on the Rotateq market, request a sample here.

What are the major opportunities in the Rotateq market? What are the strategies for the Rotateq market?

For detailed insights on the major opportunities and strategies in the Rotateq market, request a sample here.

How does the Rotateq market relate to the overall economy and other similar markets?

For detailed insights on Rotateq's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Rotateq industry?

For detailed insights on the mergers and acquisitions in the Rotateq industry, request a sample here.

What are the key dynamics influencing the Rotateq market growth? SWOT analysis of the Rotateq market.

For detailed insights on the key dynamics influencing the Rotateq market growth and SWOT analysis of the Rotateq industry, request a sample here.